ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,867, issued on July 21, was assigned to OliX Pharmaceuticals Inc. (Suwon-si, South Korea).
"RNAi agent targeting MYD88 and use thereof" was invented by Sun Woo Hong (Gyeonggi-do, South Korea) and June Hyun Park (Gyeonggi-do, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to an RNAi-inducing nucleic acid molecule and use thereof. An aspect of the disclosure relates to an RNAi-inducing nucleic acid molecule for inhibiting expression of myeloid differentiation primary response gene 88 (MyD88). Another aspect of the present disclosure relates to a pharmaceutical composition for treating or preventing age-relate...